SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $205,000 | -11.3% | 1,184 | -41.2% | 0.01% | -20.0% |
| Q4 2014 | $231,000 | +9.0% | 2,012 | +48.6% | 0.02% | 0.0% |
| Q3 2014 | $212,000 | +1.9% | 1,354 | -19.7% | 0.02% | 0.0% |
| Q2 2014 | $208,000 | +49.6% | 1,686 | +26.0% | 0.02% | +36.4% |
| Q1 2014 | $139,000 | +13.9% | 1,338 | -1.7% | 0.01% | +10.0% |
| Q4 2013 | $122,000 | +32.6% | 1,361 | -0.8% | 0.01% | +11.1% |
| Q3 2013 | $92,000 | -58.0% | 1,372 | -58.6% | 0.01% | -60.9% |
| Q2 2013 | $219,000 | +9.5% | 3,311 | -15.4% | 0.02% | +4.5% |
| Q1 2013 | $200,000 | +96.1% | 3,915 | +102.4% | 0.02% | +57.1% |
| Q2 2012 | $102,000 | -19.7% | 1,934 | -19.7% | 0.01% | -6.7% |
| Q1 2012 | $127,000 | +28.3% | 2,408 | +15.3% | 0.02% | +15.4% |
| Q4 2011 | $99,000 | +73.7% | 2,088 | +6.6% | 0.01% | +62.5% |
| Q3 2011 | $57,000 | – | 1,958 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |